quinazolines has been researched along with ct52923 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giese, NA; Hollenbach, SJ; Israel, MA; Lokker, NA; Sullivan, CM | 1 |
| Abe, K; Betsholtz, C; Giese, NA; Hollenbach, S; Kaminski, WE; Kozaki, K; Lindahl, P; Martin, PJ; Raines, EW; Ross, R; Sullivan, C; Tang, J; Yu, JC | 1 |
2 other study(ies) available for quinazolines and ct52923
| Article | Year |
|---|---|
Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Topics: 3T3 Cells; Animals; Brain Neoplasms; Cell Division; Cell Survival; Glioblastoma; Humans; Ligands; Lymphokines; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptors, Platelet-Derived Growth Factor; Signal Transduction | 2002 |
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Becaplermin; Blood Platelets; Mice; Mice, Knockout; Piperazines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Proto-Oncogene Proteins c-sis; Quinazolines; Receptors, Platelet-Derived Growth Factor | 2002 |